Wesley Research Institute
Donate
Now

World-First Cancer Breakthrough Tests Hundreds of Clues in One Biopsy to Guide Treatment

In a world-first discovery, doctors can now check hundreds of markers in a single biopsy to show which treatments, like immunotherapy, chemotherapy or radiotherapy, will work best for patients with head and neck cancer.


Learn More

Celebrating 30 Years of Delivering Real Health Impact

Since our founding in 1994, Wesley Research Institute (WRI) has grown into a leader in health and medical research, consistently working to improve patient outcomes.


Read More

Clinical Trials

Explore our clinical trials open for participation, with focus areas on Coeliac Disease and Immune Health, Cardiology and Critical Care, Pulmonary Hypertension, Orthopaedics, Neurology and Rare Diseases.


Learn More
I am looking for

Established in 1994, Wesley Research Institute is the official research partner for UnitingCare. Our research extends across the UnitingCare network including Lifeline, Bluecare and four private hospitals, St Andrew's War Memorial Hospital, The Wesley Hospital, Buderim Private Hospital and St Stephen's at Hervey Bay.

We predominately focus on translational research and work closely with experienced doctors, nurses and allied health professionals to deliver improved treatments, better diagnostics, and enhanced care.

We are focused on making a real difference, committed to providing better outcomes and quality of life for patients and their families, as well as building supportive communities.

Learn More About WRI

Research into faster and more accurate diagnosis

Improve understanding
around the causes of disease and better prediction of disease progression

Increase survival and quality of life for patients and families

Explore WRI

Acknowledgement of Country

We acknowledge the Turrbal and Yuggera peoples as the Traditional Custodians of the land on which Wesley Research Institute now stands. We pay our respects to Elders past, present and emerging.

Latest News & Discoveries

Tharuka’s Story: Living with Pulmonary Arterial Hypertension 

Tharuka was diagnosed with Pulmonary Arterial Hypertension (PAH)  at the age of 11. He shares with us his story, growing up with PAH, managing his condition to participating in clinical trials.

World-First Cancer Breakthrough Tests Hundreds of Clues in One Biopsy to Guide Treatment  

In a world-first discovery by the Queensland Spatial Biology Centre (QSBC), doctors can now check hundreds of markers in a single biopsy to show which treatments, like immunotherapy, chemotherapy or radiotherapy, will work best for patients with head and neck cancer. 

Living with FSHD: A Personal Journey of Strength, Hope, and Family

Meet Leona Luke: a 46-year-old mum from the Gold Coast. While her life seems like it’s all about family and fulfilling her everyday roles, Leona’s journey has been anything but typical. Leona was diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD), a progressive genetic disorder that weakens muscles over time.

Emma’s Story – A Life Transformed by Research

After 12 months of intensive treatment for breast cancer, Emma was left to navigate life after cancer on her own. She had survived, but she didn’t have the tools or support to truly thrive. That’s where research made the difference.

More Than a Diet: Jenny’s Path to Coeliac Awareness

Jenny, a coeliac disease clinical trial participant shares her story. Jenny’s 18 year journey with coeliac disease has led her to become a strong advocate for research and clinical trials.

Micro and Nanoplastics in the Human Cardiovascular System

A recent scoping review, led by Research Fellow Adrian Goldsworthy from the Wesley Research Institute, has raised concerns about the presence of micro- and nanoplastics (MNPs) in the human cardiovascular system.
1 2 3 12
See All News
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram